Vermed Develops Cost-Cutting Repositionable Electrode
Kristina Utton VP US Sales
BELLOWS FALLS, VT — Vermed, Inc., manufacturer of quality cardiac monitoring and diagnostic electrodes, now offers a new Repositionable electrode that is effective in reducing costs.
“Vermed understands that cost savings are important to hospitals,” says Kristina Utton, Vice President of US Sales for Vermed. “Our Repositionable electrode allows hospital departments to reposition the electrode instead of discarding; reducing waste and saving time.”
The Versa-Trode Repositionable electrode features a unique solid gel that allows for the electrode to be repositioned several times. “In addition to its ability to be repositioned, the electrode features a Radiolucent snap that allows it to be used in conjunction with imaging. And it’s also MR Conditional.”
Vermed is the fourth-largest supplier of disposable electrodes and related supplies used in electrocardiography, impedance cardiography and other diagnostic procedures. The company provides top-of the-line electrodes to a diverse client base of more than 4,000 medical suppliers, facilities and physicians.
The company designs, manufactures, and sells the industry’s broadest line of medical electrodes. It specializes in medical electrodes for physiological measurement applications and enjoys a worldwide reputation for top-quality products and excellent customer responsiveness.